Evidence map›Paper›PMID 38415011›Full record

SynthesisFrontiers in cellular and infection microbiology2024

Cytokine expression in subjects with

J Todd Kuenstner, Qiang Xu, Tim J Bull, Antonio C G Foddai, Irene R Grant, Saleh A Naser, Raghava Potula, Peilin Zhang, Ira Shafran, Serhat Emre Akhanli and 2 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 4 countries.

J Todd KuenstnerDepartment of Biology, Abilene Christian University, Abilene, TX, United States.
Qiang XuDepartment of Biology, Abilene Christian University, Abilene, TX, United States.
Tim J BullInstitute of Infection and Immunity, St. George's University of London, London, United Kingdom.
Antonio C G FoddaiSchool of Health and Life Sciences, Teesside University, Middlesbrough, United Kingdom.
Irene R GrantSchool of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom.
Saleh A NaserBurnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, United States.
Raghava PotulaLewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Peilin ZhangPZM Diagnostics, Charleston, WV, United States.
Ira ShafranRetired, Winter Park, FL, United States.
Serhat Emre AkhanliDepartment of Statistics, Muğla Sıtkı Koçman University, Muğla, Türkiye.
Svetlana KhaiboullinaDepartment of Microbiology and Immunology, University of Nevada, Reno, NV, United States.
Russell KruzelockDepartment of Biology, Abilene Christian University, Abilene, TX, United States.
Abilene Christian University · USCenter for Independent Living · USKazan Federal University · RUMuğla University · TRQueen's University Belfast · GBSt George's, University of London · GBTeesside University · GBTemple University · USUniversity of Central Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: 1) Culture Methods: The Temple University/Abilene Christian University (TU/ACU) study had a prospective case control design with 201 subjects including 61 CD patients and 140 non-CD controls. The culture methods included MGIT, TiKa and Pozzato broths, and were deemed MAP positive, if IS900 PCR positive. A phage amplification assay was also performed to detect MAP. Cytokine analysis of the TU/ACU samples was performed using Simple Plex cytokine reagents on the Ella ELISA system. Statistical analyses were done after log transformation using the R software package. The meta-analysis combined three studies. Results: Most subjects had MAP positive blood cultures by one or more methods in 3 laboratories. In our cytokine study comparing CD to non-CD controls, IL-17, IFNγ and TNFα were significantly increased in CD, but IL-2, IL-5, IL-10 and GM-CSF were not increased. In the meta-analysis, IL-6, IL-8 and IL-12 were significantly increased in the CD patients. Conclusion: Most subjects in our sample had MAP infection and 8 of 9 subjects remained MAP positive one year later indicating persistent infection. While not identical, cytokine expression patterns in MAP culture positive CD patients in the TU/ACU study showed similarities (increased IL-17, IFNγ and TNFα) to patterns of patients with Tuberculosis in other studies, indicating the possibilities of similar mechanisms of pathogen infection and potential strategies for treatment.

Indexed as

Crohn DiseaseMycobacterium avium subsp. paratuberculosisParatuberculosisTuberculosisAnimalsBlood CultureCytokinesHumansInterleukin-17Tumor Necrosis Factor-alphaCytokinesInterleukin-17Tumor Necrosis Factor-alphaautoimmune diseasebacteremiaCrohn’s diseaseinflammatory bowel disease (IBD)MAP

Identifiers

PMID38415011
PMCPMC10896875
OpenAlexW4391783796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.